Showing 301-310 of 7440 results for "".
INTERNATIONAL PERSPECTIVES: Learning From Counterparts Around the World
https://practicaldermatology.com/topics/feature/international-perspectives-learning-from-counterparts-around-the-world/28866/Dermatology experts share their perspectives about the value and importance of maintaining contact with dermatologist around the globe.DERM2024: Dr. Friedman on Atopic Dermatitis Diagnosis
https://practicaldermatology.com/conferences/derm2024/derm2024-dr-friedman-atopic-dermatitis-diagnosis/26731/Practical Dermatology Editorial Board member Adam Friedman, MD, FAAD, talks about his presentation “When It’s Not Eczema?” presented at The Dermatology Education Foundation’s DEF Essential Resource Meeting 2024 (DERM2024) NP/PA CME Conference.Innovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroActive Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uEczema Herpeticum in A 20-year-old Woman with a History of Atopic Dermatitis (AD) and Herpes Labialis
https://practicaldermatology.com/topics/atopic-dermatitis/eczema-herpeticum-in-a-20-year-old-woman-with-a-history-of-atopic-dermatitis-ad-and-herpes-labialis/24037/Eczema herpeticum (EH), also known as Kaposi Varicelliform Eruption, is a potentially life-threatening herpes simplex virus (HSV) infection superimposed over eczematous skin. Typical EH presents as monomorphic, umbilicated vesicles on an erythematous base that progress to punched-out erosions with hAcross the Lifespan: Understanding the Cutaneous Impact of Hormonal Fluctuations on Women’s Skincare
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/across-the-lifespan-understanding-the-cutaneous-impact-of-hormonal-fluctuations-on-womens-skincare/24027/Drs. Hope Mitchell, Mary Lupo, and Elizabeth Houshmand, talk with Practical Dermatology® about the unique challenges of tailoring women’s skincare to their specific needs.Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatology